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Erratum Vol. 8, No. 1
In the article, “A Large Outbreak of Legionnaires’ Disease at a Flower Show, the Netherlands,” by Jeroen W. Den Boer et al., errors appear in two fig-
ures and their legends. 
In Figure 3, part 3a should be identified as IgM and part 3b as IgG. The correct legends are as follows:
Figure 3a. Smoothed mean geometric immunoglobulin (Ig) M antibody titers to Legionella pneumophila of nearest 35 exhibitors in Halls 3 and 4 per
63 cm2 of exhibition area; confirmed and probable cases among exhibitors in halls 3 and 4.
●  = confirmed case in exhibitor;  ❍ = probable case in exhibitor; 
Bu = bubblemat; W = whirlpool spa. 
Figure 3b. Smoothed mean geometric IgG antibody titers to L. pneumophila of 35 exhibitors nearest to whirlpool in halls 3 and 4 per 63 cm2 of exhi-
bition area; exhibitors ill with confirmed and probable cases in halls 3 and 4.
●  = confirmed case in exhibitor; ❍ = probable case in exhibitor; 
Bu = bubblemat; W = whirlpool spa. 
In Figure 4, parts b and c were inadvertently omitted. The complete figure appears below. The correct legends are as follows:
Figure 4. Exhibition hall, West Frisian Flower Show, Bovenkarspel, the Netherlands, 1999. 
4a. Circles indicate locations in water-supply system where water samples were taken. PE = polyethylene.
4b. Assessment of risk for Legionella pneumophila infection, by distance from water-using devices.
4c. Water samples taken and culture status, by distance from water-using devices.
We regret any confusion these errors may have caused. The article is corrected online, available at http://www.cdc.gov/ncidod/eid/vol8no1/01-0176.htm